Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Gross Margin

Aerie Pharmaceuticals Gross Margin Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Gross Margin from 2018 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Aerie Pharmaceuticals Gross Margin for the quarter ending June 06, 2020 was $59m a 2.64% increase of 2m year over year
  • Aerie Pharmaceuticals Gross Margin for the last 12 months ending June 06, 2020 was $61m a 10.89% increase of 7m year over year
  • Aerie Pharmaceuticals Annual Gross Margin for 2019 was $61m a 120.54% increase of 73m from 2018
  • Aerie Pharmaceuticals Annual Gross Margin for 2018 was $-12m
Other Margins & Efficiency Metrics:
  • Aerie Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -52.21 a -6.48% increase of 3.38 year over year
  • Aerie Pharmaceuticals Return on Equity % for the quarter ending September 09, 2018 was -147.39 a -7.71% increase of 11.36 year over year
View Chart On Koyfin

Quarterly AERI Gross Margin Data

06/2020$59m
03/2020$60m
12/2019$66m
09/2019$57m
06/2019$59m
03/2019$55m
12/2018$45m
09/2018$-2m
06/2018$-182m

Annual AERI Gross Margin Data

2019$61m
2018$-12m